Efficacy and Safety of a Single Dose versus a Multiple Dose Regimen of Mebendazole against Hookworm Infections in Children: A Randomised, Double-blind Trial

Marta S Palmeirim, Shaali M Ame, Said M Ali, Jan Hattendorf, Jennifer Keiser, Marta S Palmeirim, Shaali M Ame, Said M Ali, Jan Hattendorf, Jennifer Keiser

Abstract

Background: Single-dose mebendazole is widely used in preventive chemotherapy against the soil-transmitted helminths (STHs) Ascaris lumbricoides, hookworm and Trichuris trichiura, yet it shows limited efficacy against hookworm and T. trichiura infections. The use of adapted treatment regimens might provide a strategy to control and eliminate STH infections in STH-persistent settings. We evaluated the safety and efficacy of the multiple dose mebendazole regimen (3 days 100 mg bid) versus a single dose of 500 mg mebendazole in a setting with high STH prevalence and high drug pressure.

Methods: This randomised, double-blind clinical trial took place in a primary school on Pemba Island, Tanzania, in school-aged children (6-12 years). Using a computer random number generator (block size 10), hookworm-positive children were randomly assigned (1:1) to either a single or multiple dose regimen of mebendazole by an independent statistician. Two stool samples were collected at baseline and follow-up (18 to 22 days after treatment) for Kato-Katz analysis. The primary outcome was cure rate (CR) against hookworm. Secondary outcomes were egg reduction rate (ERR) against hookworm, CRs and ERRs against A. lumbricoides and T. trichiura, and tolerability assessed 3, 24 and 48 h post-treatment. Participants, investigators, caregivers, outcome assessors and the trial statistician were blinded. This trial is registered with ClinicalTrials.gov, number NCT03245398.

Findings: 93 children were assigned to each treatment arm. 185 children completed treatment and provided follow-up stool samples. CR against hookworm was significantly higher in the multiple dose (98%) than in the single dose arm (13%, OR 389.1, 95% CI 95.2 to 2885.7%, p < 0.001). 34 and 42 children reported mild adverse events in the single and multiple dose arms, respectively. The most common events were abdominal pain, headache and diarrhoea.

Interpretation: The poor performance of single dose mebendazole against hookworm infections was confirmed, but the multiple dose treatment regimen of mebendazole showed high efficacy. Hence, multiple dose mebendazole might provide a treatment strategy in given epidemiological situations to boost control and elimination of STH infections.

Funding: PATH.

Figures

Fig. 1
Fig. 1
Trial profile.
Fig. 2
Fig. 2
Spider plot indicating the percentage of observed clinical symptoms (before treatment) and adverse events in both treatment arms (throughout all seven adverse event assessment time points).

References

    1. Jourdan P.M., Lamberton P.H.L., Fenwick A., Addiss D.G. Soil-transmitted helminth infections. Lancet. 2018;391:252–265.
    1. GBD 2016 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(2017):1260–1344.
    1. Bartsch S.M., Hotez P.J., Asti L. The global economic and health burden of human hookworm infection. PLoS Negl Trop Dis. 2016;10
    1. Guideline W.H.O. World Health Organization; Geneva: 2017. Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups.
    1. Moser W., Schindler C., Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ. 2017;358
    1. Geerts S., Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev. 2000;13:207–222.
    1. Albonico M., Chwaya H.M., Montresor A. Parasitic infections in Pemba Island school children. East Afr Med J. 1997;74:294–298.
    1. Albonico M., Rinaldi L., Sciascia S. Comparison of three copromicroscopic methods to assess albendazole efficacy against soil-transmitted helminth infections in school-aged children on Pemba Island. Trans R Soc Trop Med Hyg. 2013;107:493–501.
    1. Speich B., Ame S.M., Ali S.M. Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med. 2014;370:610–620.
    1. Ministry of Health and Social Welfare of the United Republic of Tanzania . 2013. Standard treatment guidelines and essential medicines list.
    1. WHO . World Health Organization; Geneva: 1995. WHO model prescribing information: drugs used in parasitic diseases.
    1. FDA Highlights of prescribing information: Vermox. June 2017. [accessed 30 April 2018]
    1. Lionel N.D. Mebendazole in the treatment of intestinal helminthiasis with special reference to whipworm infection. J Trop Med Hyg. 1975;78:75–77.
    1. Charoenlarp P., Waikagul J., Muennoo C., Srinophakun S., Kitayaporn D. Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. Southeast Asian J Trop Med Public Health. 1993;24:712–716.
    1. Maipanich W., Pubampen S., Sa-Nguankiat S., Nontasut P., Waikagul J. Effect of albendazole and mebendazole on soil-transmitted helminth eggs. Southeast Asian J Trop Med Public Health. 1997;28:321–325.
    1. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14:397–400.
    1. Speich B., Ali S.M., Ame S.M., Albonico M., Utzinger J., Keiser J. Quality control in the diagnosis of Trichuris trichiura and Ascaris lumbricoides using the Kato-Katz technique: experience from three randomised controlled trials. Parasit Vectors. 2015;8:82.
    1. Farahmandian I., Arfaa F., Jalali H., Reza M. Comparative studies on the evaluation of the effect of new anthelminthics on various intestinal helminthiasis in Iran. Effects of anthelminthics on intestinal helminthiasis. Chemotherapy. 1977;23:98–105.
    1. Wesche D., Barnish G. A comparative study of the effectiveness of mebendazole (Janssen) and generically equivalent mebendazole (Nordia) in intestinal helminthiasis in Papua New Guinean children. P N G Med J. 1994;37:7–11.
    1. Zani L.C., Favre T.C., Pieri O.S., Barbosa C.S. Impact of antihelminthic treatment on infection by Ascaris lumbricoides, Trichuris trichiura and hookworms in Covas, a rural community of Pernambuco, Brazil. Rev Inst Med Trop Sao Paulo. 2004;46:63–71.
    1. WHO . World Health Organization; Geneva: 2002. Helminth control in school age children: A guide for managers of control programmes.
    1. Lustigman S., Prichard R.K., Gazzinelli A. A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis. 2012;6
    1. Renganathan E., Ercole E., Albonico M. Evolution of operational research studies and development of a national control strategy against intestinal helminths in Pemba Island, 1988–92. Bull World Health Organ. 1995;73:183–190.
    1. Abadi K. Single dose mebendazole therapy for soil-transmitted nematodes. Am J Trop Med Hyg. 1985;34:129–133.
    1. Arundel J.H., Boersema J.H., Bruyning C.F.A. Springer Science & Business Media; 2012. Chemotherapy of gastrointestinal helminths.
    1. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ. 2003;81:343–352.
    1. Blayney D.W., McGuire B.W., Cruickshank S.E., Johnson D.H. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma. Oncologist. 2005;10:138–149.
    1. Flohr C., Tuyen L.N., Lewis S. Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials. Am J Trop Med Hyg. 2007;76:732–736.
    1. Steinmann P., Utzinger J., Du Z.W. Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial. PLoS One. 2011;6
    1. Sacko M., De Clercq D., Behnke J.M., Gilbert F.S., Dorny P., Vercruysse J. Comparison of the efficacy of mebendazole, albendazole and pyrantel in treatment of human hookworm infections in the southern region of Mali, West Africa. Trans R Soc Trop Med Hyg. 1999;93:195–203.
    1. Knopp S., Mohammed K.A., Speich B. Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial. Clin Infect Dis. 2010;51:1420–1428.
    1. WHO . Geneva World Health Organization. 2005. Deworming for health and development: report of the third global meeting of the Partners for Parasite Control.
    1. Gabrielli A.F., Montresor A., Chitsulo L., Engels D., Savioli L. Preventive chemotherapy in human helminthiasis: theoretical and operational aspects. Trans R Soc Trop Med Hyg. 2011;105:683–693.
    1. Truscott J., Hollingsworth T.D., Anderson R. Modeling the interruption of the transmission of soil-transmitted helminths by repeated mass chemotherapy of school-age children. PLoS Negl Trop Dis. 2014;8

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel